PHI 27 features a peptide motif with balanced hydrophobic, polar, and basic residues that influence folding and solubility. Structural flexibility supports studies of receptor interaction and signaling mechanisms. Researchers analyze its domain-level transitions and hydrogen-bonding patterns. Applications span bioactive peptide modeling, structural research, and sequence-function mapping.
CAT No: R2334
CAS No:80458-29-3
Synonyms/Alias:80458-29-3;CID 16132346;PHI 27;L-Isolecucinamide, L-histidyl-L-alanyl-L-alpha-aspartylglycyl-L-valyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-phenylalanyl-L-seryl-L-arginyl-L-leucyl-L-leucylglycyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-lysyl-L-lysyl-L-tyrosyl-L-leucyl-L-alpha-glutamyl-L-seryl-L-leucyl-;FP73565;NCGC00167207-01;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More